Security
Guardant Health, Inc. Common Stock · GH
GHNASDAQCommon stockCurrentCIK 1576280Updated Oct 23, 2026
GH price & chart
Loading TradingView…
NASDAQ:GH on TradingView ↗About the company
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 1,276,786,000Source | 1,538,727,000Source | 1,912,294,000Source | 1,331,999,000Source | 1,609,340,000Source | 1,915,291,000Source | 1,344,226,000Source | 1,704,598,000Source | 2,013,659,000Source | 1,485,609,000Source | 1,786,421,000Source | 1,609,985,000Source |
| Property, Plant and Equipment, NetUSD | 124,609,000Source | 125,169,000Source | 155,299,000Source | 126,141,000Source | 132,317,000Source | 150,035,000Source | 129,294,000Source | 138,387,000Source | 145,915,000Source | 136,813,000Source | 145,096,000Source | 167,920,000Source |
| GoodwillUSD | 3,290,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 3,290,000Source | 3,290,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 5,477,000Source | 7,251,000Source | 25,267,000Source | 5,864,000Source | 7,742,000Source | 25,543,000Source | 6,280,000Source | 8,294,000Source | 25,921,000Source | 6,760,000Source | 8,979,000Source | 11,727,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 580,013,000Source | 585,022,000Source | 1,053,469,000Source | 629,143,000Source | 933,694,000Source | 989,291,000Source | 698,572,000Source | 1,029,027,000Source | 378,203,000Source | 525,540,000Source | 1,133,537,000Source | 141,647,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 115,585,000Source | 88,465,000Source | 144,249,000Source | 130,252,000Source | 100,519,000Source | 137,404,000Source | 115,426,000Source | 84,562,000Source | 137,849,000Source | 110,253,000Source | 88,783,000Source | 97,256,000Source |
| Inventory, NetUSD | 90,489,000Source | 72,298,000Source | 105,463,000Source | 84,061,000Source | 66,984,000Source | 83,851,000Source | 77,256,000Source | 62,991,000Source | 85,876,000Source | 71,083,000Source | 61,948,000Source | 51,598,000Source |
| Assets, CurrentUSD | 828,885,000Source | 1,226,715,000Source | 1,364,639,000Source | 883,432,000Source | 1,289,974,000Source | 1,367,505,000Source | 927,026,000Source | 1,308,546,000Source | 1,466,046,000Source | 1,055,114,000Source | 1,347,106,000Source | 1,191,594,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 42,798,000Source | 66,883,000Source | 61,458,000Source | 39,976,000Source | 87,232,000Source | 43,490,000Source | 35,772,000Source | 31,736,000Source | 40,723,000Source | 33,800,000Source | 27,741,000Source | 31,509,000Source |
| Operating Lease, Right-of-Use AssetUSD | 163,550,000Source | 144,964,000Source | 147,566,000Source | 169,768,000Source | 146,111,000Source | 153,906,000Source | 140,500,000Source | 151,881,000Source | 158,849,000Source | 142,265,000Source | 157,616,000Source | 174,001,000Source |
| Other Assets, NoncurrentUSD | 41,473,000Source | 31,338,000Source | 27,996,000Source | 37,167,000Source | 29,906,000Source | 28,895,000Source | 32,555,000Source | 94,200,000Source | 28,457,000Source | 37,152,000Source | 124,334,000Source | 61,453,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,631,259,000Source | 1,598,823,000Source | 2,135,161,000Source | 1,637,474,000Source | 1,610,953,000Source | 2,096,364,000Source | 1,595,015,000Source | 1,636,313,000Source | 2,112,966,000Source | 1,625,256,000Source | 1,627,737,000Source | 1,549,805,000Source |
| Stockholders’ equity: | ||||||||||||
| Additional Paid in CapitalUSD | 2,560,814,000Source | 2,410,416,000Source | 3,009,424,000Source | 2,516,550,000Source | 2,363,501,000Source | 2,930,665,000Source | 2,472,272,000Source | 2,329,930,000Source | 2,900,056,000Source | 2,443,788,000Source | 2,304,220,000Source | 1,742,114,000Source |
| Retained Earnings (Accumulated Deficit)USD | -2,866,018,000Source | -2,467,229,000Source | -3,226,729,000Source | -2,773,293,000Source | -2,359,475,000Source | -3,106,587,000Source | -2,673,394,000Source | -2,256,847,000Source | -2,994,512,000Source | -2,578,235,000Source | -2,141,862,000Source | -1,662,413,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -4,260,000Source | -3,284,000Source | -5,563,000Source | -3,723,000Source | -5,640,000Source | -5,152,000Source | -4,658,000Source | -4,799,000Source | -4,852,000Source | -5,201,000Source | -3,675,000Source | -19,522,000Source |
| Stockholders' Equity Attributable to ParentUSD | -354,473,000Source | -60,096,000Source | -222,867,000Source | -305,475,000Source | -1,613,000Source | -181,073,000Source | -250,789,000Source | 68,285,000Source | -99,307,000Source | -139,647,000Source | 158,684,000Source | 60,180,000Source |
| Liabilities and EquityUSD | 1,276,786,000Source | 1,538,727,000Source | 1,912,294,000Source | 1,331,999,000Source | 1,609,340,000Source | 1,915,291,000Source | 1,344,226,000Source | 1,704,598,000Source | 2,013,659,000Source | 1,485,609,000Source | 1,786,421,000Source | 1,609,985,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 236,919,000Source | 197,345,000Source | 338,962,000Source | 238,430,000Source | 201,569,000Source | 292,145,000Source | 225,753,000Source | 220,009,000Source | 302,730,000Source | 225,583,000Source | 205,917,000Source | 193,220,000Source |
| Operating Lease, Liability, CurrentUSD | 26,395,000Source | 27,383,000Source | 27,758,000Source | 26,277,000Source | 27,663,000Source | 28,030,000Source | 29,666,000Source | 27,957,000Source | 27,679,000Source | 29,213,000Source | 27,950,000Source | 21,878,000Source |
| Accounts Payable, CurrentUSD | 20,142,000Source | 15,473,000Source | 93,514,000Source | 44,802,000Source | 42,447,000Source | 75,034,000Source | 49,770,000Source | 37,603,000Source | 54,442,000Source | 38,551,000Source | 51,741,000Source | 68,911,000Source |
| Operating Lease, Liability, NoncurrentUSD | 185,387,000Source | 170,131,000Source | 166,312,000Source | 192,348,000Source | 172,194,000Source | 173,055,000Source | 160,378,000Source | 178,907,000Source | 178,463,000Source | 164,292,000Source | 185,848,000Source | 210,015,000Source |
| Other Liabilities, NoncurrentUSD | 94,359,000Source | 89,446,000Source | 126,944,000Source | 91,170,000Source | 95,934,000Source | 127,693,000Source | 92,545,000Source | 96,786,000Source | 127,773,000Source | 92,834,000Source | 96,006,000Source | 9,179,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 71,707,000Source | 71,671,000Source | 79,291,000Source | 71,011,000Source | 70,680,000Source | 78,013,000Source | 76,003,000Source | 67,211,000Source | 77,889,000Source | — | 187,952,000Source | — |
| Deferred Revenue, CurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 17,403,000Source |
| Long-term DebtUSD | 1,114,594,000Source | — | 1,502,943,000Source | 1,115,526,000Source | — | 1,503,471,000Source | 1,116,339,000Source | — | 1,504,000,000Source | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -107,754,000Source | — | — | — | -95,159,000Source | — | -436,373,000Source | -479,449,000Source | -654,588,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 9,442,000Source | 10,236,000Source | 39,736,000Source | 42,387,000Source | 42,881,000Source | 35,962,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 47,608,000Source | 37,757,000Source | 166,217,000Source | 140,411,000Source | 90,759,000Source | 94,685,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -942,000Source | 6,115,000Source | 28,175,000Source | 21,389,000Source | -8,378,000Source | -375,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -2,025,000Source | 6,173,000Source | 14,792,000Source | 9,135,000Source | 10,350,000Source | 20,926,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -1,705,000Source | 287,000Source | -541,000Source | -236,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -65,623,000Source | -62,689,000Source | -184,760,000Source | -239,858,000Source | -324,975,000Source | -309,463,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 58,988,000Source | — | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 699,418,000Source | 302,864,000Source | -627,202,000Source | -261,308,000Source | 840,250,000Source | 149,816,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | -1,531,000Source | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 5,580,000Source | 4,459,000Source | 48,306,000Source | 35,085,000Source | 20,486,000Source | 77,461,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 20,650,000Source | 15,497,000Source | 30,535,000Source | 15,681,000Source | 11,197,000Source | 7,878,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 0Source | 45,010,000Source | 45,010,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -21,577,000Source | -66,850,000Source | 671,133,000Source | -996,000Source | 477,375,000Source | -189,093,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | -4,476,000Source | -3,000Source | 3,596,000Source | -153,000Source | 6,028,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 612,024,000Source | 174,098,000Source | -140,338,000Source | -503,932,000Source | 991,739,000Source | -350,340,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 689,515,000Source | 688,368,000Source | 1,167,739,000Source | 735,480,000Source | 1,101,441,000Source | 803,853,000Source | 489,417,000Source | 629,755,000Source | 1,133,687,000Source | 141,948,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 3,771,000Source | — | — | — |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 869,000Source | 1,007,000Source | 1,969,000Source | 1,331,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 42,808,000Source | 49,769,000Source | 57,725,000Source | 42,462,000Source | 47,608,000Source | 37,757,000Source | 166,217,000Source | 140,411,000Source | 90,759,000Source | 94,685,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | 768,000Source | 645,000Source | 1,182,000Source | 764,000Source | 1,178,000Source | 702,000Source | 3,243,000Source | 2,581,000Source | 2,575,000Source | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | — | — | — | — | 2,569,000Source |
| Amortization of Intangible AssetsUSD | — | — | 400,000Source | 500,000Source | 300,000Source | 400,000Source | 400,000Source | 500,000Source | 1,700,000Source | 2,200,000Source | 2,700,000Source | 2,500,000Source |
| Debt Securities, Realized Gain (Loss)USD | — | — | 0Source | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| DepreciationUSD | — | — | 9,000,000Source | 10,100,000Source | 9,300,000Source | 9,600,000Source | 9,100,000Source | 9,800,000Source | 38,100,000Source | 40,100,000Source | 40,000,000Source | 33,400,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | — | — | — | — | — | — | — | 0Source | 0Source | -44,401,000Source | — | — |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | 79,710,000Source | -7,793,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | -99,785,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | 0Source | 13,672,000Source | 13,672,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 53,266,000Source | 49,129,000Source | 61,660,000Source | 50,259,000Source | 57,926,000Source | 46,952,000Source | 211,410,000Source | 180,123,000Source | 155,800,000Source | 163,956,000Source |
| GoodwillUSD | — | — | 3,290,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 77,257,000Source | 3,290,000Source | 3,290,000Source | 3,290,000Source |
| Income Tax Expense (Benefit)USD | — | — | 136,000Source | 30,000Source | 185,000Source | 38,000Source | 372,000Source | 290,000Source | -1,263,000Source | 1,284,000Source | 685,000Source | 1,139,000Source |
| InterestExpenseNonoperatingUSD | — | — | 943,000Source | 646,000Source | 1,346,000Source | 983,000Source | 1,347,000Source | 791,000Source | 3,897,000Source | 2,581,000Source | — | — |
| Investment Income, InterestUSD | — | — | 7,391,000Source | 13,257,000Source | 10,199,000Source | 7,560,000Source | 11,151,000Source | 9,112,000Source | 34,095,000Source | 53,691,000Source | 35,365,000Source | 6,069,000Source |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | — | -7,800,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -92,725,000Source | -107,754,000Source | -120,142,000Source | -99,899,000Source | -112,075,000Source | -95,159,000Source | -416,277,000Source | -436,373,000Source | -479,449,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -92,725,000Source | -107,754,000Source | -120,142,000Source | -99,899,000Source | -112,075,000Source | -95,159,000Source | -416,277,000Source | -436,373,000Source | -479,449,000Source | -654,588,000Source |
| Operating Lease, ExpenseUSD | — | — | 8,600,000Source | 8,100,000Source | 8,600,000Source | 8,600,000Source | 8,600,000Source | 7,900,000Source | 33,600,000Source | 31,100,000Source | 29,700,000Source | 28,600,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -48,000Source | -3,007,000Source | 308,000Source | -25,000Source | -157,000Source | 7,851,000Source | -10,490,000Source | -42,605,000Source | 53,174,000Source | -12,778,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 257,128,000Source | 0Source | 493,116,000Source | 0Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | — | — | — | — | 307,323,000Source | 307,323,000Source | 35,000,000Source | 1,494,700,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 3,651,000Source | 768,000Source | 19,223,000Source | 3,119,000Source | 405,000Source | 2,625,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | — | — | — | — | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 265,196,000Source | 191,476,000Source | 334,978,000Source | 232,088,000Source | 301,665,000Source | 203,471,000Source | 982,021,000Source | 739,016,000Source | 563,948,000Source | 449,538,000Source |
| Cost of RevenueUSD | — | — | 93,587,000Source | 74,489,000Source | 115,949,000Source | 81,205,000Source | 104,919,000Source | 74,723,000Source | 349,007,000Source | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Income (Loss)USD | — | — | -98,989,000Source | -117,328,000Source | -129,118,000Source | -106,413,000Source | -121,350,000Source | -111,041,000Source | -437,248,000Source | -443,594,000Source | -564,725,000Source | -544,378,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -48,000Source | -3,007,000Source | 308,000Source | -25,000Source | -157,000Source | 7,851,000Source | -10,490,000Source | -42,605,000Source | 53,174,000Source | -12,778,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -92,589,000Source | -107,724,000Source | -119,957,000Source | -99,861,000Source | -111,703,000Source | -94,869,000Source | -417,540,000Source | -435,089,000Source | -478,764,000Source | -653,449,000Source |
| Income Tax Expense (Benefit)USD | — | — | 136,000Source | 30,000Source | 185,000Source | 38,000Source | 372,000Source | 290,000Source | -1,263,000Source | 1,284,000Source | 685,000Source | 1,139,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -92,725,000Source | -107,754,000Source | -120,142,000Source | -99,899,000Source | -112,075,000Source | -95,159,000Source | -416,277,000Source | -436,373,000Source | -479,449,000Source | — |
| Earnings Per Share, BasicUSD per share | — | — | -0.74Source | -0.88Source | -0.9Source | -0.8Source | -0.85Source | -0.77Source | -3.32Source | -3.56Source | -4.28Source | -6.41Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.74Source | -0.88Source | -0.9Source | -0.8Source | -0.85Source | -0.77Source | -3.32Source | -3.56Source | -4.28Source | -6.41Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 124,807,000Source | 123,051,000Source | 132,867,000Source | 124,114,000Source | 131,273,000Source | 123,871,000Source | 125,374,000Source | 122,745,000Source | 111,988,000Source | 102,178,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 124,807,000Source | 123,051,000Source | 132,867,000Source | 124,114,000Source | 131,273,000Source | 123,871,000Source | 125,374,000Source | 122,745,000Source | 111,988,000Source | 102,178,000Source |
| Interest Expense (non-operating)USD | — | — | 943,000Source | 646,000Source | 1,346,000Source | 983,000Source | 1,347,000Source | 791,000Source | 3,897,000Source | 2,581,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 400,000Source | 500,000Source | 300,000Source | 400,000Source | 400,000Source | 500,000Source | 1,700,000Source | 2,200,000Source | 2,700,000Source | 2,500,000Source |
| Costs and ExpensesUSD | — | — | 364,185,000Source | 308,804,000Source | 464,096,000Source | 338,501,000Source | 423,015,000Source | 314,512,000Source | 1,419,269,000Source | 1,182,610,000Source | 1,128,673,000Source | 993,916,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 442,000Source | 997,000Source | 1,226,000Source | 1,375,000Source |
| Debt Securities, Realized Gain (Loss)USD | — | — | 0Source | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | -99,785,000Source |
| General and Administrative ExpenseUSD | — | — | 53,266,000Source | 49,129,000Source | 61,660,000Source | 50,259,000Source | 57,926,000Source | 46,952,000Source | 211,410,000Source | 180,123,000Source | 155,800,000Source | 163,956,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -413,482,000Source | -437,179,000Source | -481,405,000Source | -659,757,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 2,578,000Source | 2,577,000Source |
| Interest Expense, DebtUSD | — | — | 943,000Source | 645,000Source | 1,346,000Source | 983,000Source | 1,347,000Source | 791,000Source | 3,897,000Source | — | — | — |
| Investment Income, InterestUSD | — | — | 7,391,000Source | 13,257,000Source | 10,199,000Source | 7,560,000Source | 11,151,000Source | 9,112,000Source | 34,095,000Source | 53,691,000Source | 35,365,000Source | 6,069,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -92,725,000Source | -107,754,000Source | -120,142,000Source | -99,899,000Source | -112,075,000Source | -95,159,000Source | -416,277,000Source | -436,373,000Source | -479,449,000Source | -654,588,000Source |
| Operating Lease, ExpenseUSD | — | — | 8,600,000Source | 8,100,000Source | 8,600,000Source | 8,600,000Source | 8,600,000Source | 7,900,000Source | 33,600,000Source | 31,100,000Source | 29,700,000Source | 28,600,000Source |
| Other Cost and Expense, OperatingUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 83,400,000Source | — |
| Research and Development ExpenseUSD | — | — | 89,957,000Source | 87,306,000Source | 96,533,000Source | 87,449,000Source | 91,038,000Source | 88,521,000Source | 364,191,000Source | 347,753,000Source | 367,194,000Source | 373,807,000Source |
| Selling and Marketing ExpenseUSD | — | — | 127,375,000Source | 97,880,000Source | 189,954,000Source | 119,588,000Source | 169,132,000Source | 104,316,000Source | 494,661,000Source | 364,935,000Source | 295,227,000Source | 299,828,000Source |
Offerings
Registration 333-297841
Filing attachments
d121100dex42.htm · S-3ASR · 2026-07-30
Exhibit 4.2 GUARDANT HEALTH, INC. INDENTURE Dated as of ___________, 20___ U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION Trustee TABLE OF CONTENTS Page ARTICLE I. DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1. Definitions 1 Section 1.2. Other Definitions …
Read attachment ↗d66171dex41.htm · 8-K · 2025-11-07
EX-4.1 3 d66171dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 GUARDANT HEALTH, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of November 7, 2025 0% Convertible Senior Notes due 2033 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Co…
Read attachment ↗d66171dex991.htm · 8-K · 2025-11-07
EX-99.1 5 d66171dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Guardant Health Announces Pricing of Upsized Public Offering of Common Stock PALO ALTO, Calif. November 5, 2025 - Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced the pricing of an upsized underwritten public offering of 3,333,333 shares of Guardant Health’s common stock at a public offering price of $90.00 per share (the “common stock offering”). The size of the common sto…
Read attachment ↗d66171dex992.htm · 8-K · 2025-11-07
EX-99.2 6 d66171dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering PALO ALTO, Calif. November 5, 2025 - Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced the pricing of its upsized offering of $350.0 million aggregate principal amount of 0% convertible senior notes due 2033 (the “notes”) in a private offering (the “convertible notes offering”) to persons reasona…
Read attachment ↗d891468dex41.htm · 8-K · 2025-02-14
EX-4.1 2 d891468dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 GUARDANT HEALTH, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of February 14, 2025 1.25% Convertible Senior Notes due 2031 TABLE OF CONTENTS Page Article 1. Definitions; Rule…
Read attachment ↗d931211dex991.htm · 8-K · 2025-02-07
EX-99.1 3 d931211dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Guardant Health Announces Debt Exchange Transactions PALO ALTO, Calif. February 7, 2025 - Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it entered into privately negotiated exchange agreements (the “Exchange Agreements”) with certain holders of its outstanding 0% Convertible Senior Notes due 2027 (the “2027 Notes”), pursuant to which the Company will issue $600 mi…
Read attachment ↗